Akari Therapeutics PLC (AKTX)
1.34
-0.02
(-1.47%)
USD |
NASDAQ |
May 06, 16:00
1.32
-0.02
(-1.49%)
Pre-Market: 09:06
Akari Therapeutics Total Return Level: 1.34 for May 6, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 06, 2024 | 1.34 |
May 03, 2024 | 1.36 |
May 02, 2024 | 1.47 |
May 01, 2024 | 1.70 |
April 30, 2024 | 1.54 |
April 29, 2024 | 1.280 |
April 26, 2024 | 1.185 |
April 25, 2024 | 1.19 |
April 24, 2024 | 1.19 |
April 23, 2024 | 1.21 |
April 22, 2024 | 1.18 |
April 19, 2024 | 1.166 |
April 18, 2024 | 1.21 |
April 17, 2024 | 1.121 |
April 16, 2024 | 1.156 |
April 15, 2024 | 1.20 |
April 12, 2024 | 1.21 |
April 11, 2024 | 1.10 |
April 10, 2024 | 1.30 |
April 09, 2024 | 1.315 |
April 08, 2024 | 1.40 |
April 05, 2024 | 1.41 |
April 04, 2024 | 1.44 |
April 03, 2024 | 1.55 |
April 02, 2024 | 1.51 |
Date | Value |
---|---|
April 01, 2024 | 1.51 |
March 28, 2024 | 1.865 |
March 27, 2024 | 1.86 |
March 26, 2024 | 1.885 |
March 25, 2024 | 1.900 |
March 22, 2024 | 1.81 |
March 21, 2024 | 1.83 |
March 20, 2024 | 1.900 |
March 19, 2024 | 1.94 |
March 18, 2024 | 2.000 |
March 15, 2024 | 1.97 |
March 14, 2024 | 2.04 |
March 13, 2024 | 2.15 |
March 12, 2024 | 2.14 |
March 11, 2024 | 2.150 |
March 08, 2024 | 2.14 |
March 07, 2024 | 2.22 |
March 06, 2024 | 2.20 |
March 05, 2024 | 2.260 |
March 04, 2024 | 2.25 |
March 01, 2024 | 2.28 |
February 29, 2024 | 2.35 |
February 28, 2024 | 2.22 |
February 27, 2024 | 2.29 |
February 26, 2024 | 2.372 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.10
Minimum
Apr 11 2024
77.60
Maximum
Feb 19 2021
25.66
Average
30.84
Median
Mar 11 2020
Total Return Level Benchmarks
DBV Technologies SA | 0.67 |
Cellectis SA | 3.35 |
Adaptimmune Therapeutics PLC | 1.13 |
Biodexa Pharmaceuticals Plc | 1.11 |
NuCana PLC | 3.88 |